24-Title: Influence of meloxicam on pharmacokinetic alterations of moxifloxacin in male goats
Authors: Nilesh R Rathod, Swapnil V Kukade, Milindmitra K Lonare and Sunil W Hajare
Source: Ruminant Science (2015)-4(1):103-108.
How to cite this manuscript: Rathod Nilesh R, Kukade Swapnil V, Lonare Milindmitra K and Hajare Sunil W (2015). Influence of meloxicam on pharmacokinetic alterations of moxifloxacin in male goats. Ruminant Science 4(1):103-108.
Combinational use of anti-microbial and anti-inflammatory agents in veterinary practice is very common, thus there are every chances of alteration of pharmacokinetics of each other. The present study was carried out to investigate the effect of meloxicam on pharmacokinetic of moxifloxacin in male berari goats of vidarbha region of Maharashtra. For this purpose, single intramuscular dose of moxifloxacin (5 mg/kg) was administered alone and concomitantly with meloxicam (0.5 mg/kg IM). The plasma drug concentration of moxifloxacin was assayed by microbiological assay (ATCC-25922TM) at different time interval. The mean peak plasma concentration (Cmax) of moxifloxacin following its single dose administration and in co-administration with meloxicam in male goats was 18.77 ± 0.30 and 14.70±0.42 mg ml-1, and time required to attain the peak concentration (Tmax) was 3.33±0.42 and 1.33 ± 0.21 h, respectively. The elimination half-life (t½) and elimination rate () were not significantly altered in meloxicam co-treated male goats as compared with moxifloxacin alone treated group. Apparent volume of distribution area (Vd (area)) and total body clearance (CLB), of moxifloxacin were significantly higher (P< 0.01) in meloxicam concomitant administered goats. Results of present investigation conclude that administration of meloxicam during the treatment along with moxifloxacin can alter the disposition kinetics of moxifloxacin in berari goats.
Ahmed FA, Mohan P, Barua CC and Dutta DJ (2005). Effect of intramuscular diclofenac sodium on pharmacokinetics of intravenous enrofloxacin in calves. Indian Journal of Pharmacology 37(3):189-190.
Bambeke FV, Michot JM, Eldere JV and Tulkens PM (2005). Quinolones: An update. Clinical Microbiology Infection 11(4):256-280.
Bennett JV, Brodie JL, Benner EJ and Kirby WMM (1966). Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens. Applied Microbiology 14 (2):170-177.
Bhavsar SK, Sadariya KA, Gothi AK, Patel SD, Patel HV and Thaker AM (2010). Pharmacokinetic interaction of moxifloxacin and meloxicam following intramuscular administration in rats. International Journal Pharmaceutical Science 1(1):27-34.
Bowden Chris and Dämmgen Jürgen (2009). Rescue of Indian vultures – role of meloxicam? Veterinary Sciences Tomorrow.
Carceles CM, Escudero E, Fernandez-Varon E and Marin P (2009). Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. Veterinary Journal 180(3):343-347.
Dumka VK and Srivastava AK (2007). Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofloxacin in cross bred calves. Iranian Journal of Veterinary Research 8(4):313-318.
Dumka VK, Sandhu HS and Rajput N (2010). Plasma levels, pharmacokinetics and dosage regimen of intravenously administered gatifloxacin in buffalo calves (Bubalus bubalis) on coadministration with meloxicam. Brazilian Journal Veterinary Research Animal Sciences, Sao Paulo 47(6):461-467.
Goudah A (2008). Disposition kinetics of moxifloxacin in lactating ewes. Veterinary Journal 178:282-287.
Joly V, Pangon B, Brion N, Vallois JM and Carbon C (1988). Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac. Journal of Veterinary Pharmacology and Therapeutics 246:695-700.
Kumar N, Singh SD and Jayachandra NC (2003). Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin and Its Interaction with Diclofenac after intravenous administration in buffalo calves. Veterinary Journal 165:302-306.
Kumar Nitesh (2005). Pharmacokinetic and immunological interactions of pefloxacin and meloxicam in goats. PhD Thesis submitted to Rajendra Agricultural University, Bihar, India.
Kumar Nitesh, Singh SD and Jayachandran C (2003). Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin and its interaction with diclofenac after intravenous administration in buffalo calves. Veterinary Journal 165:302-306.
Notari RE (1980). Biopharmaceutics and clinical pharmacokinetics-An introduction. 4th Edn, Marcell dekker Inc. New York.
Patel HB, Mody SK, Patel HB, Patel VA and Patel UD (2011). Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats. ISRN Veterinary Science 2011:5.
Pathania R and Sharma SK (2010). Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves. Research in Veterinary Science 89:108-112.
Petersen U, Dalhoff A and Endermann R (1996). Synthesis and in vitro activity of BAY 12-8039, a new 8-methoxy-quinolone. In Program and abstracts of the 36th Inter science Conference onAntimicrob. Agents Chemother. American Society for Microbiology, Washington, DC. F1, p 100.
Raipuria M, Dumka VK, sandhu HS and Ram D (2006). Gatiûoxacin pharmacokinetics in buffalo calves after single intramuscular administration. Veterinary Achieves 76:471-478.
Shrivastava AK and Bal MS (1994). Principles and Calculation in Pharmacokinetics. Punjab Agricultural University, Ludhiana.
Sidhu PK, Landoni MF and Lees P (2006). Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbo.oxacin in goats. Research in Veterinary Science 80:79-90.
Snedecor CG and Cochran WG (1994). Statistical Methods. Iowa State University Press, Ames, Iowa
Toppo R, Roy BK and Mishra AK (2011). Effects of concurrent administration of meloxicam on pharmacokinetic parameters of enrofloxacin in turkeys. Journal of Bioanal Biomedical 3(6):108-112.
Toutain PL and Bousquet A (2004). Volume of distribution. Journal of Veterinary Pharmacology and Therapeutics 27:441-453.
Winters RE, Litwack KD and Hewitt WL (1971). Family member between dose and levels of gentamicin in blood. Journal of Infectious Diseases 124:S90-S95.